UCLA researchers receive $13.9 million CIRM grant to identify drug targets for autism and schizophrenia using human stem cell models

By Tiare Dunlap – UCLA Health –

A team of researchers led by UCLA’s Dr. Daniel Geschwind has received a $13.9 million grant from the California Institute for Regenerative Medicine to use human stem cell-based models to uncover the molecular and cellular mechanisms underlying autism and schizophrenia and to identify drug targets for both conditions.

READ MORE – Click here to read the article

Related posts:

UCLA scientists awarded $21.8 million in CIRM grants to advance novel stem-cell based therapies $4.96 million CIRM grant awarded to Sanford Burnham Prebys to help the tiniest patients UCLA researchers engineer experimental drug for preventing heart failure after heart attacks